| Income Statement |
| Operating Expenses | 6.68M |
|
| Research and Development Expense | 4.32M |
| Selling, General and Administrative Expense | 2.36M |
| Operating Income | -6.68M |
| Net Income | -6.57M |
| Net Income Common Stock | -6.57M |
| Net Income Common Stock (USD) | -6.57M |
| Consolidated Income | -6.57M |
| Earnings per Basic Share | -0.64 |
| Earnings per Basic Share (USD) | -0.64 |
| Earnings per Diluted Share | -0.64 |
| Earning Before Interest & Taxes (EBIT) | -6.57M |
| Earning Before Interest & Taxes (USD) | -6.57M |
| Weighted Average Shares | 10.24M |
| Weighted Average Shares Diluted | 10.24M |
| Balance Sheet |
| Cash and Equivalents | 22.46M |
| Cash and Equivalents (USD) | 22.46M |
| Investments | 2.48M |
| Investments Current | 2.48M |
| Current Assets | 25.99M |
| Total Assets | 25.99M |
| Current Liabilities | 3.03M |
| Total Liabilities | 3.03M |
| Accumulated Retained Earnings (Deficit) | -112.23M |
| Accumulated Other Comprehensive Income | 106.00 |
| Shareholders Equity | 22.96M |
| Shareholders Equity (USD) | 22.96M |
| Trade and Non-Trade Payables | 687.11K |
| Cash Flow |
| Net Cash Flow from Financing | 18.91M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 14.52M |
| Issuance (Purchase) of Equity Shares | 18.91M |
| Net Cash Flow from Investing | 2.53M |
| Net Cash Flow - Investment Acquisitions and Disposals | 2.53M |
| Net Cash Flow from Operations | -6.92M |
| Share Based Compensation | 362.28K |